Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    44,380 result(s) found. Displaying page 1,100 of 2,219.
    «« First « Previous 1096  1097  1098  1099  1100  1101  1102  1103  1104  Next» Last»»
    EudraCT Number: 2010-019206-16 Sponsor Protocol Number: EBP-FHC-2010-3 Start Date*: 2010-05-12
    Sponsor Name:Medicinsk Forskning, Regionshospitalet Holstebro
    Full Title: Effekten af atorvastatin på NO-systemet patienter med type 2 diabetes med nefropati
    Medical condition: Diabetisk Nefropati Formålet er at måle effekten af atorvastatin på L-NMMA inducerede ændringer i den renale tubulære transport af natrium og vand , central hæmodynamik og vasoaktive hormoner hos...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10012638 Diabetes with renal manifestations LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001020-20 Sponsor Protocol Number: NKV101983 Start Date*: 2005-01-25
    Sponsor Name:GlaxoSmithKline Group of Companies
    Full Title:
    Medical condition: Chemotherapy Induced Nausea and Vomiting (CINV) 0 Moderately Emetogenic Chemotherapy (MEC)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) IE (Completed) SK (Completed) HU (Completed) AT (Completed) GB (Completed) DE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-004010-17 Sponsor Protocol Number: ANG206 Start Date*: 2004-12-09
    Sponsor Name:Amersham plc and its Amersham Health affiliates, trading as GE Healthcare
    Full Title: An open-label, multi-centre, phase 2a study to assess the feasibility and safety of intravenous bolus administration of 99mTc-NC100692 Injection in imaging metastases in late stage cancer patients.
    Medical condition: The subjects to be included in this study have been diagnosed with primary breast, lung (non-small cell), ovarian or prostate cancer or malignant melanoma and have metastatic spread of the cancer t...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended) GB (Completed) DE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-000219-24 Sponsor Protocol Number: 3082A-101342 Start Date*: 2005-04-28
    Sponsor Name:Wyeth Pharmaceuticals
    Full Title: A multicentre study to describe the immunogenic epitope(s) of factor VIII in previously treated patients with congenital haemophilia A who develop de novo factor VIII inhibitors while receiving fac...
    Medical condition: Haemophilia A is an X-linked recessive clotting disorder in which the clotting factor, factor VIII (FVIII), is deficient or inactive. Patients with low levels of FVIII have an increased tendency t...
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) BE (Completed) ES (Completed) DE (Prematurely Ended) IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-008366-13 Sponsor Protocol Number: 3.0edition Start Date*: 2009-03-17
    Sponsor Name:Unit for Psychiatric Research
    Full Title: Comparison of the effects of Sertindole and Olanzapine on Cognition
    Medical condition: Cognitive deficits in patients with schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019364 Hebephrenic schizophrenia LLT
    9.1 10046150 Unspecified schizophrenia LLT
    9.1 10052792 Schizophrenia, undifferentiated type LLT
    9.1 10007780 Catatonic schizophrenia LLT
    9.1 10033877 Paranoid type schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017420-75 Sponsor Protocol Number: SM1-plp-09 Start Date*: 2010-01-25
    Sponsor Name:Joergen B Dahl
    Full Title: Effekten af transversus abdominis plane (TAP) blok på patienter, der får foretaget laparoskopisk cholcystektomi i dagkirurgisk regi
    Medical condition: Postoperative pain in patients undergoing laparoscopic cholecystectomy
    Disease: Version SOC Term Classification Code Term Level
    12.1 10036236 Postoperative pain relief LLT
    12.1 10036276 Postoperative analgesia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000975-32 Sponsor Protocol Number: RPCE03L1801 Start Date*: 2004-11-09
    Sponsor Name:UCB S.A. - Pharma Sector
    Full Title: An exploratory, double blind, randomized, placebo-controlled, prallel group, multicenter study, for the assessment of the efficacy, safety and tolerability of ucb34714 50mg oral capsules in b.i.d. ...
    Medical condition: post-herpetic neuralgia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) CZ (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2004-000904-41 Sponsor Protocol Number: XRP0673A/2002 Start Date*: 2004-10-14
    Sponsor Name:Aventis Pharmaceuticals Inc.
    Full Title: A multinational, randomized, double-blind, double-dummy, exploratory, parallel-group, dose-ranging phase II study to evaluate the pharmacodynamics, the safety and tolerability, and the pharmacokine...
    Medical condition: Patients with coronary heart disease who will be undergoing non-urgent Percutaneous Coronary Intervention (PCI)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SK (Completed) ES (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2004-002089-39 Sponsor Protocol Number: CFOR258F2402 Start Date*: 2004-10-20
    Sponsor Name:Novartis Pharma AG
    Full Title: A randomized, multi-center, placebo controlled 24 week study to compare the efficacy and safety of formoterol Certihaler™ 10µg b.i.d., tiotropium HandiHaler® 18µg o.d. and tiotropium HandiHaler® 1...
    Medical condition: Stable chronic obstructive pulmonary disease
    Disease: Version SOC Term Classification Code Term Level
    10010952
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) ES (Completed) CZ (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-000370-31 Sponsor Protocol Number: NKT102260 Start Date*: 2005-05-20
    Sponsor Name:GlaxoSmithKline Group of Companies
    Full Title: A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of the Oral Neurokinin-1 Receptor Ant...
    Medical condition: Post Operative Nausea and Vomiting (PONV) Post Discharge Nausea and Vomiting (PDNV)
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: HU (Completed) BE (Completed) DE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-000022-75 Sponsor Protocol Number: CV131-169 Start Date*: 2004-09-24
    Sponsor Name:Bristol-Myers Squibb International Corporation
    Full Title: Irbesartan Versus Placebo in Combination with Standard Cardiovascular Protection ACE-I Therapy with Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk
    Medical condition: Albuminuria in hypertensive subjects at increased cardiovascular risk.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed) LV (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-018448-15 Sponsor Protocol Number: SJ-127 Start Date*: 2010-03-23
    Sponsor Name:Obstetrisk afd., Hvidovre Hospital
    Full Title: Effekten af præoperativ enkeltdosis methylprednisolon på det postoperative forløb efter abdominal hysterektomi: Et prospektivt, dobbeltblindet, placebo-kontrolleret studie.
    Medical condition: Postoperative pain after abdominal hysterectomy
    Disease: Version SOC Term Classification Code Term Level
    12.1 10000075 Abdominal hysterectomy LLT
    12.1 10054711 Postoperative pain LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-018245-21 Sponsor Protocol Number: H-A-2009-069 Start Date*: 2010-06-22
    Sponsor Name:Rigshospitalet
    Full Title: Fibrinklæber ved bilateral knæalloplastik – et prospektivt randomiseret studie med fokus på: blodtab, smerte, ROM, hævelse og styrke
    Medical condition: Formålet med nærværende studie er at undersøge om – og i bekræftende fald omfanget heraf – fibrinklæber (Evicel) reducerer blødningen efter Total Knæ Alloplastik (kunstigt knæ)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10044094 Total knee replacement LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-020599-47 Sponsor Protocol Number: MED.RES.HOS.2010.02.SM Start Date*: 2010-06-29
    Sponsor Name:Departments of Medical Research and Medicine
    Full Title: The effect of Amiloride and Spironolacton on renophysiological and cardiovascular parametres in patients with hypertension
    Medical condition: Hypertension
    Disease: Version SOC Term Classification Code Term Level
    12.1 10004254 Benign essential hypertension LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-020179-22 Sponsor Protocol Number: 14042010 Start Date*: 2010-08-31
    Sponsor Name:Department of Dermatology
    Full Title: Konventionel vs. fraktioneret CO2 laser-assisteret fotodynamisk terapi af non melanom hudcancer og forstadier hertil
    Medical condition: Aktiniske keratoser og nodulære basalcellecarcinomer
    Disease: Version SOC Term Classification Code Term Level
    12.1 10000614 Actinic keratosis LLT
    12.1 10004146 Basal cell carcinoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000091-14 Sponsor Protocol Number: FFR102123 Start Date*: 2004-09-17
    Sponsor Name:GlaxoSmithKline, S.A
    Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg ...
    Medical condition: Perennial allergic rhinitis
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) SE (Completed) LV (Completed) LT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-001341-14 Sponsor Protocol Number: BAY 59-7939 / 11527 Start Date*: 2004-11-04
    Sponsor Name:Bayer HealthCare AG
    Full Title: Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXaHIP-OD Study
    Medical condition: Deep Venous Thrombosis prophylaxis
    Disease: Version SOC Term Classification Code Term Level
    7.0 10012108
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) SE (Completed) AT (Completed) ES (Completed) GB (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-001955-12 Sponsor Protocol Number: A3711030 Start Date*: 2005-01-19
    Sponsor Name:Pfizer Limited
    Full Title: A double blind, placebo controlled, parallel group, multicenter study to assess the duration of action, safety and toleration of differing doses and combinations of immediate and modified release f...
    Medical condition: Male Erectile Dysfunction
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed) DE (Completed) BE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-001190-25 Sponsor Protocol Number: A6291015 Start Date*: 2004-12-17
    Sponsor Name:Pfizer Ltd
    Full Title: A Double-blind, Proof of Concept Trial of the Use of Pegvisomant to Reduce Urinary Albumin Excretion in Type 1 and Type 2 Diabetic Patients Treated with Angiotensin Convertase Inhibitors/Angiotensi...
    Medical condition: Diabetic nephropathy DN (Diabetes mellitus (DM) type I and type II with renal manifestations). MedDRA classification code : 10061835, 10045236 and 10045250 (Version 7.0, Level LLT)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed) CZ (Completed) DE (Completed) GB (Completed) ES (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-015752-22 Sponsor Protocol Number: gymoese007 Start Date*: 2009-11-24
    Sponsor Name:Bent Gymoese Jørgensen
    Full Title: Tilsætning af sufentanil til interskalenerblokade ved skulderoperation
    Medical condition: Postoperative smerter efter arthroskopisk skulderoperation
    Disease: Version SOC Term Classification Code Term Level
    12.0 10003393 Arthropathy, unspecified, involving shoulder region LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 1096  1097  1098  1099  1100  1101  1102  1103  1104  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Feb 11 17:03:27 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA